Industry says failure to consider new ways of assessing the value of drugs, including outcomes-based approaches and the use of real world evidence, represents a missed opportunity to promote sustainability of Europe’s healthcare systems
After being hit by delays and spiralling costs, the world’s biggest science project is finally making headway towards the ambition of proving fusion is a viable energy source
Investment in R&D in Europe rose above world average in 2016, but there is persistent weakness in digital innovation and companies are increasingly outsourcing research to academic partners, potentially displacing basic university research
Sector deal features 25 investments from global companies and a pledge by government to provide funding for research infrastructure and long-term capital to allow start-ups to scale
Brexit, austerity, ageing and more could disrupt healthcare R&D in Europe. At a Science|Business Network dinner, guests debated what could be done about it
Longstanding concern that central and eastern member states are not as successful in EU research as western peers needs greater attention, ministers say, warning that east-west split will harm negotiating hand in EU budget talks
The Science|Business Network picks fields where European companies and research bodies can catch the innovation wave, and suggests ways the EU can ensure this happens
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.